Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHTG Molecular Diagnostics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/10/2023 | Q1 2023 | N/A | -$2.28 | N/A | N/A | $1.03 M |
| 03/30/2023 | Q4 2022 | N/A | -$5.28 | N/A | N/A | $2.44 M |
| 11/10/2022 | Q3 2022 | -$6.24 | -$4.91 | 1.33 | N/A | $1.25 M |
| 08/11/2022 | Q2 2022 | N/A | -$6.42 | N/A | N/A | $1.49 M |
| 05/12/2022 | Q1 2022 | -$8.52 | -$9.73 | -1.21 | N/A | $1.18 M |
| 03/29/2022 | Q4 2021 | -$7.44 | -$0.06 | 7.38 | N/A | $2.88 M |
| 11/10/2021 | Q3 2021 | -$7.20 | -$0.05 | 7.15 | N/A | $2.52 M |
| 08/12/2021 | Q2 2021 | -$9.48 | -$0.03 | 9.45 | N/A | $2.07 M |
| 05/13/2021 | Q1 2021 | -$11.40 | -$0.07 | 11.33 | N/A | $1.44 M |
| 03/25/2021 | Q4 2020 | -$13.50 | -$0.06 | 13.44 | N/A | $2.58 M |
| 11/10/2020 | Q3 2020 | -$12.60 | -$0.09 | 12.51 | N/A | $1.78 M |
| 08/11/2020 | Q2 2020 | -$14.40 | -$0.11 | 14.29 | N/A | $1.96 M |
| 05/13/2020 | Q1 2020 | -$14.40 | -$0.11 | 14.29 | N/A | $2.23 M |
| 03/25/2020 | Q4 2019 | -$14.40 | -$0.09 | 14.32 | N/A | $4.80 M |
| 11/12/2019 | Q3 2019 | -$25.20 | -$0.19 | 25.01 | N/A | $5.40 M |
| 08/06/2019 | Q2 2019 | -$27.00 | -$0.21 | 26.79 | N/A | $5.80 M |
| 05/09/2019 | Q1 2019 | -$30.60 | -$0.23 | 30.37 | N/A | $3.20 M |
| 03/07/2019 | Q4 2018 | -$36.00 | -$0.09 | 35.91 | N/A | $7.73 M |
| 11/08/2018 | Q3 2018 | -$34.20 | -$0.21 | 33.99 | N/A | $4.71 M |
| 08/08/2018 | Q2 2018 | N/A | -$0.18 | N/A | N/A | $4.91 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
HTG Molecular Diagnostics, Inc. Earnings: FAQ's
HTG Molecular Diagnostics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 9th, 2023 based offlast year's report dates.
The conference call for HTG Molecular Diagnostics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for HTG Molecular Diagnostics, Inc.'s latest earnings report can be read online.
HTG Molecular Diagnostics, Inc. (:HTGM) has a recorded annual revenue of $6.37 M.
HTG Molecular Diagnostics, Inc. (:HTGM) has a recorded net income of $-21,594,476.HTG Molecular Diagnostics, Inc. has generated $-24.28 earnings per share over the last four quarters.
HTG Molecular Diagnostics, Inc. (:HTGM) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is -0.